{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:46:14Z","timestamp":1773981974182,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004955","name":"\u00d6sterreichische Forschungsf\u00f6rderungsgesellschaft","doi-asserted-by":"publisher","award":["415 854452"],"award-info":[{"award-number":["415 854452"]}],"id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bbadis.2018.11.006","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T17:37:08Z","timestamp":1541785028000},"page":"308-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacologic IL-6R\u03b1 inhibition in cholangiocarcinoma promotes cancer cell growth and survival"],"prefix":"10.1016","volume":"1865","author":[{"given":"Florian","family":"Kleinegger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Wodlej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Golob-Schwarzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Birkl-Toeglhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Stallinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Orlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Krassnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Reihs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Niedrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Mangge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Thalhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Aigelsreiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurd","family":"Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Garbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Rose-John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Moriggl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Rinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.11.006_bb0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s004230100220","article-title":"Carcinogenesis of malignant lesions of the gall bladder: the impact of chronic inflammation and gallstones","volume":"386","author":"Tazuma","year":"2001","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12029-011-9284-y","article-title":"Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates","volume":"43","author":"Rustagi","year":"2012","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0025","doi-asserted-by":"crossref","first-page":"21214","DOI":"10.1074\/jbc.C110.129502","article-title":"Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes","volume":"285","author":"Xu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0030","doi-asserted-by":"crossref","first-page":"d340","DOI":"10.2741\/A136","article-title":"Molecular and cellular biology of interleukin-6 and its receptor","volume":"1","author":"Keller","year":"1996","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0035","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0045","doi-asserted-by":"crossref","first-page":"51096","DOI":"10.18632\/oncotarget.9315","article-title":"The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth","volume":"7","author":"Nivarthi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jhbp.131","article-title":"STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression","volume":"21","author":"Dokduang","year":"2014","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0923-2494(92)80013-B","article-title":"IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130","volume":"143","author":"Taga","year":"1992","journal-title":"Res. Immunol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0060","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.149.6.2021","article-title":"Complex of soluble human IL-6-receptor\/IL-6 up-regulates expression of acute-phase proteins","volume":"149","author":"Mackiewicz","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0065","doi-asserted-by":"crossref","first-page":"14804","DOI":"10.1074\/jbc.M111.229393","article-title":"Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding","volume":"286","author":"Garbers","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0070","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.180.11.7102","article-title":"Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells","volume":"180","author":"Briso","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0075","doi-asserted-by":"crossref","first-page":"38829","DOI":"10.1074\/jbc.M210584200","article-title":"Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)","volume":"278","author":"Matthews","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2000080","article-title":"Proteolytic origin of the soluble human IL-6R in vivo and a decisive role of N\u2011glycosylation","volume":"15","author":"Riethmueller","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0085","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.7314\/APJCP.2014.15.13.5443","article-title":"An interleukin-6 receptor polymorphism is associated with opisthorchiasis-linked cholangiocarcinoma risk in Thailand","volume":"15","author":"Prayong","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.gastro.2006.10.037","article-title":"Sustained IL-6\/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing","volume":"132","author":"Isomoto","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0095","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1572-0241.2007.01403.x","article-title":"Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy","volume":"102","author":"Cheon","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0100","doi-asserted-by":"crossref","DOI":"10.2217\/hep.13.4","article-title":"A perspective on molecular therapy in cholangiocarcinoma: present status and future directions","volume":"1","author":"Andersen","year":"2014","journal-title":"Hepatic Oncol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000658-199803000-00012","article-title":"Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker","volume":"227","author":"Goydos","year":"1998","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0110","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3892\/mmr.2014.3143","article-title":"Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0115","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1158\/0008-5472.CAN-06-2130","article-title":"Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression","volume":"66","author":"Wehbe","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28874","article-title":"IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice","volume":"65","author":"Bergmann","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0130","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1073\/pnas.0501794102","article-title":"IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation","volume":"102","author":"McLoughlin","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0135","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"Il-6 trans-signaling via the soluble IL-6 receptor: importance for the proinflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.182.1.613","article-title":"Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis","volume":"182","author":"Nowell","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0150","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/CCM.0b013e318211ff56","article-title":"Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model","volume":"39","author":"Barkhausen","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0155","doi-asserted-by":"crossref","first-page":"89736","DOI":"10.18632\/oncotarget.21116","article-title":"IMP2\/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer","volume":"8","author":"Kessler","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2017.06.003","article-title":"New liver cancer biomarkers: PI3K\/AKT\/mTOR pathway members and eukaryotic translation initiation factors","volume":"83","author":"Golob-Schwarzl","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0165","series-title":"Separation of Low and High Grade Colon and Rectum Carcinoma by Eukaryotic Translation Initiation Factors 1, 5 and 6","first-page":"101224","volume":"8","author":"Golob-Schwarzl","year":"2017"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0170","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.26721","article-title":"Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway","volume":"59","author":"Goeppert","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nbt0297-142","article-title":"A bioactive designer cytokine for human hematopoietic progenitor cell expansion","volume":"15","author":"Fischer","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0190","doi-asserted-by":"crossref","first-page":"15285","DOI":"10.1016\/S0021-9258(18)82467-X","article-title":"Structure-function analysis of interleukin-6 utilizing human\/murine chimeric molecules: involvement of two separate domains in receptor binding","volume":"268","author":"Van Dam","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0195","doi-asserted-by":"crossref","first-page":"27200","DOI":"10.1074\/jbc.M803694200","article-title":"Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130","volume":"283","author":"Tenhumberg","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","article-title":"Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses","volume":"268","author":"Jostock","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2144\/000113083","article-title":"TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays","volume":"46","author":"Gebaeck","year":"2009","journal-title":"Biotechniques"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0210","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0215","article-title":"Cholangiocarcinoma: treatment with sorafenib extended life expectancy to greater than four years","volume":"4","author":"Chakunta","year":"2013","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0220","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1038\/s41598-017-09333-8","article-title":"High mRNA expression level of IL-6R was associated with better prognosis for patients with ovarian cancer: a pooled meta-analysis","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0225","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2061::AID-CNCR12>3.0.CO;2-O","article-title":"Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma","volume":"88","author":"Karczewska","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0230","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1186\/s12885-015-1950-1","article-title":"Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells","volume":"15","author":"Holmer","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0235","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0006-291X(02)00706-4","article-title":"The effect of gp130 stimulation on glutamate-induced excitotoxicity in primary hippocampal neurons","volume":"295","author":"Sun","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0240","doi-asserted-by":"crossref","first-page":"19014","DOI":"10.1016\/S0021-9258(17)32267-6","article-title":"Identification of a region within the cytoplasmic domain of the interleukin-6 (IL-6) signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptor","volume":"269","author":"Dittrich","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0245","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports RasDependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0250","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7150\/ijbs.15153","article-title":"Mitochondrial Stat3, the need for design thinking","volume":"12","author":"Yang","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0255","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2005.10.030","article-title":"Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes","volume":"44","author":"Meng","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0260","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.510300522","article-title":"Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line","volume":"30","author":"Park","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.11.006_bb0265","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3892\/ol.2015.3019","article-title":"Anti-proliferative action of IL-6r-targeted antibody tocilizumab for non-small cell lung cancer cells","volume":"9","author":"Kim","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0270","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1158\/1078-0432.CCR-15-1139","article-title":"CD126 and targeted therapy with tocilizumab in chronic lymphocytic leukemia","volume":"22","author":"Liu","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2018.11.006_bb0275","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2007-01-067918","article-title":"Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils","volume":"110","author":"Chalaris","year":"2007","journal-title":"Blood"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918304514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918304514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:44:27Z","timestamp":1760417067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918304514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0925443918304514"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.11.006","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic IL-6R\u03b1 inhibition in cholangiocarcinoma promotes cancer cell growth and survival","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}